Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.037 AUD | 0.00% | +8.82% | -11.90% |
Valuation
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 119.4 | 119.4 | 32.94 | 46.94 | 43.22 | 49.39 |
Enterprise Value (EV) 1 | 142.7 | 127.5 | 51.76 | 59.14 | 62.36 | 59.9 |
P/E ratio | -0.96 x | -0.62 x | -0.56 x | 1.81 x | -2.61 x | -1.34 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.29 x | 1.38 x | 0.62 x | 4.55 x | 17.7 x | 2.03 x |
EV / Revenue | 1.54 x | 1.48 x | 0.97 x | 5.73 x | 25.6 x | 2.46 x |
EV / EBITDA | 3.36 x | 7.34 x | 6.45 x | -47.6 x | -10.5 x | 6.76 x |
EV / FCF | 7.24 x | 5.39 x | -90.7 x | -2.34 x | 30.5 x | 2.84 x |
FCF Yield | 13.8% | 18.6% | -1.1% | -42.8% | 3.28% | 35.2% |
Price to Book | 0.32 x | 0.62 x | 0.24 x | 0.29 x | 0.28 x | 0.41 x |
Nbr of stocks (in thousands) | 823,593 | 823,593 | 823,593 | 1,235,389 | 1,234,727 | 1,234,727 |
Reference price 2 | 0.1450 | 0.1450 | 0.0400 | 0.0380 | 0.0350 | 0.0400 |
Announcement Date | 27/09/18 | 27/09/19 | 30/10/20 | 29/09/21 | 28/09/22 | 29/09/23 |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 92.61 | 86.26 | 53.49 | 10.32 | 2.437 | 24.33 |
EBITDA 1 | 42.49 | 17.36 | 8.03 | -1.243 | -5.956 | 8.864 |
EBIT 1 | 32.51 | 7.235 | -2.068 | -9.673 | -13.55 | 2.278 |
Operating Margin | 35.1% | 8.39% | -3.87% | -93.73% | -555.96% | 9.37% |
Earnings before Tax (EBT) 1 | -120.6 | -190.2 | -56.39 | 26.2 | -16.61 | -36.08 |
Net income 1 | -124.5 | -194 | -58.89 | 25.18 | -16.49 | -36.75 |
Net margin | -134.45% | -224.88% | -110.1% | 243.98% | -676.69% | -151.06% |
EPS 2 | -0.1503 | -0.2355 | -0.0715 | 0.0210 | -0.0134 | -0.0298 |
Free Cash Flow 1 | 19.71 | 23.66 | -0.571 | -25.31 | 2.047 | 21.07 |
FCF margin | 21.28% | 27.43% | -1.07% | -245.3% | 84.01% | 86.6% |
FCF Conversion (EBITDA) | 46.39% | 136.28% | - | - | - | 237.69% |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 27/09/18 | 27/09/19 | 30/10/20 | 29/09/21 | 28/09/22 | 29/09/23 |
Balance Sheet Analysis
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 23.3 | 8.06 | 18.8 | 12.2 | 19.1 | 10.5 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 0.5489 x | 0.4642 x | 2.344 x | -9.812 x | -3.214 x | 1.186 x |
Free Cash Flow 1 | 19.7 | 23.7 | -0.57 | -25.3 | 2.05 | 21.1 |
ROE (net income / shareholders' equity) | -29% | -68.5% | -35.7% | 16.6% | -10.5% | -28% |
ROA (Net income/ Total Assets) | 3.64% | 1.2% | -0.53% | -2.95% | -4.25% | 0.75% |
Assets 1 | -3,424 | -16,228 | 11,140 | -854.8 | 387.9 | -4,916 |
Book Value Per Share 2 | 0.4500 | 0.2400 | 0.1700 | 0.1300 | 0.1200 | 0.1000 |
Cash Flow per Share 2 | 0.0600 | 0.0300 | 0.0200 | 0.0100 | 0 | 0.0100 |
Capex 1 | 5.67 | 5.65 | 1.08 | 0.19 | 0 | 0.13 |
Capex / Sales | 6.12% | 6.55% | 2.02% | 1.82% | 0.08% | 0.55% |
Announcement Date | 27/09/18 | 27/09/19 | 30/10/20 | 29/09/21 | 28/09/22 | 29/09/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-11.90% | 29.79M | |
+7.14% | 33.01B | |
+5.10% | 24.32B | |
+22.35% | 20.52B | |
-18.63% | 19.87B | |
-18.07% | 19.35B | |
-1.08% | 16.62B | |
-4.07% | 9.51B | |
-21.91% | 7.92B | |
+6.70% | 7.13B |
- Stock Market
- Equities
- DNA Stock
- Financials Donaco International Limited